Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

February 28, 2007

Slides

Topic 3: Introduction – Strain Selection for the Influenza Virus Vaccine for the 2007 – 2008 Season, Rakesh, Pandey, Ph.D. (ppt) (htm)

Topic 3: U.S. Surveillance, Anthony Fiore, M.D. (ppt) (htm)

Topic 3: World Surveillance/Strain Characterization, Nancy Cox, Ph.D. (ppt) (htm)

Topic 3: Vaccine Effectiveness Report, Angela Owens, M.P.H. (ppt) (htm)

Topic 3: Vaccine Responses, Zhiping Ye, Ph.D. (ppt) (htm)

Topic 3: Availability of Strain Reagents, Galina Vodeiko, Ph.D. (ppt) (htm)

Topic 3: Comments from Manufacturers, Albert Thomas (ppt) (htm)

Topic 3: Strain Selection Options/Questions, Rakesh Pandey, Ph.D. (ppt) (htm)

Topic 3: Influenza A (H5N1) Virus Update, Nancy Cox, Ph.D. (ppt) (htm)

Topic 4: Introduction – Influenza Type B Strain – Discussion on Circulating Lineages, Jerry Weir, Ph.D. (ppt) (htm)

Topic 4: Background and Presentation of Possible Vaccine Options, Robert Couch, M.D. (ppt) (htm)

Topic 4: Regulatory Implications for Alternative Vaccine Options, Sara Gagneten, Ph.D. (ppt) (htm)

Topic 4: Comments from Manufacturers, Tony Colegate (ppt) (htm)

Open Public Hearing Speakers

Topic 2: Open Public Hearing – GlaxoSmithKline, Dr. Bruce Innis (ppt) (htm)

Topic 2: Open Public Hearing – Protein Sciences, Manon Cox (ppt) (htm)

---

Up | AC Home Page